Vanda Pharmaceuticals Aktie
WKN DE: A0JJT3 / ISIN: US9216591084
21.07.2017 13:21:15
|
Vanda Pharma Gets Negative Opinion From European Medicines Agency On Fanaptum
(RTTNews) - Vanda Pharmaceuticals Inc. (VNDA) said that the European Medicines Agency's Committee for Medicinal Product for Human Use or CHMP has adopted a negative opinion recommending against the marketing authorization of Fanaptum or oral iloperidone tablets for the treatment of schizophrenia in adult patients in the European Union.
The CHMP was of the opinion that the benefits of Fanaptum did not outweigh its risks and recommended against marketing authorization. Vanda intends to appeal this opinion and request a re-examination by the CHMP.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Vanda Pharmaceuticals IncShsmehr Nachrichten
12.02.25 |
Ausblick: Vanda Pharmaceuticals präsentiert Quartalsergebnisse (finanzen.net) |
Analysen zu Vanda Pharmaceuticals IncShsmehr Analysen
Aktien in diesem Artikel
Vanda Pharmaceuticals IncShs | 3,98 | -3,40% |
|